Eli Lilly (NYSE:LLY) is scheduled to release its earnings report on Thursday, May 1, 2025. For event-driven traders, historical stock performance following earnings announcements may offer ...

Eli Lilly’s LLY first-quarter revenue grew 45 ... We think price competition with Novo and other future competitors means non-GAAP performance margin (similar to operating margin) could only ...

The stock carries a hefty premium, but it is justified by the company's growth and the size of the market for GLP-1s. Eli Lilly's Q1 report ... The positive performance was driven by the ...

Eli Lilly's Q1 numbers showed strong revenue and earnings growth, driven by its GLP-1 offerings. The company's 2025 outlook disappointed investors, however, leading to the decline. The stock ...

Learn More » *Stock prices used were the afternoon prices of May 16, 2025. The video was published on May 18, 2025. Should you invest $1,000 in Eli Lilly right now? Before you buy stock in Eli ...

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Eli Lilly? Access our full analysis report here ...

Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year.

Eli Lilly (NYSE:LLY) is set to disclose its earnings report on Thursday, May 1, 2025. For traders focused on events, the historical stock performance following earnings announcements can provide ...

Despite beating on its earnings Thursday, pharma giant Eli Lilly (LLY) suffered a nearly 12% loss in its stock, losing more than $90 billion in market cap in a single day. "We think the market ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the ... robust financial performance, and innovative ...